New fluorine chemistry research may help in the development of medicines and materials

September 29, 2014, University of Southern California
New fluorine chemistry research may help in the development of medicines and materials
This figure from USC Dornsife chemistry research recently published in the German journal Angewandte Chemie was featured as the cover. Credit: Fang Wang.

In a recent study, USC Loker Hydrocarbon Research Institute chemists have dispelled a long-held notion regarding the ubiquitous fluorine-containing trifluoromethyl group.

The trifluoromethyl group is significant in chemistry dealing with pharmaceutical drug development and materials chemistry. Fluorine-containing compounds are part of many human-made materials, from the polymer Teflon used to coat pots and pans to medical drugs.

For example, drugs such as Prozac (for depression), Celebrex (a non-steroidal anti-inflammatory agent), Mefloquine (for malaria) and Sevflurane (a general anesthetic) all contain the trifluoromethyl group.

"Fluorine is the kingpin of drug discovery and many of the modern drugs contain one or more fluorine atoms," said G.K. Surya Prakash, professor and George A. and Judith A. Olah Nobel Laureate Chair in Hydrocarbon Chemistry, and institute director.

For more than six decades, scientists believed that the trifluoromethanide anion, produced within the course of a chemical reaction involving the trifluoromethyl group, exists only fleetingly and could not be stabilized. However, Prakash, Karl Christe and George Olah have isolated and proven the existence of a stable, long-lived form of the anion.

Their findings will help guide future research in medicinal and , expanding the potential for creating new used to develop pharmaceuticals, agricultural and industrial materials.

For chemists, introducing fluorine into organic molecules is an important way of controlling properties such as the bioactivity of drugs and the performance of plastics and electronic materials.

For the past 25 years, Prakash has worked in fluorine chemistry. He co-discovered the Ruppert-Prakash reagent, which is widely used in multi-ton quantities by the pharmaceutical industry and researchers around the world.

The research was published this past summer in Angewandte Chemie, an international journal published by the German Chemical Society, and on Sept. 8 in Chemical & Engineering News, the flagship journal of the American Chemical Society. Angewandte Chemie highlighted the research as a "Very Important Paper," a distinction reserved for less than 10 percent of its submissions, and featured a research figure from the paper as the cover of that issue.

Until now, the trifluoromethanide anion was believed to have a fleeting lifespan in the intermediate stages of a chemical reaction—in the order of millionths of a second—before decomposing into difluorocarbene and fluoride. But Prakash suspected otherwise, despite a lack of direct evidence.

"As I always say to my students, when you're buying a property, you say 'location, location, location,' " Prakash said. "Well, in organic synthesis, you say 'conditions, conditions, conditions.' We managed to find the right conditions to look at this species at low temperatures with an appropriate metal counter cation."

Using thermodynamics calculations, the researchers discovered that low temperatures enabled the isolation of the trifluoromethanide anion and allowed it to survive for days at a time, thus addressing major misconceptions.

"I am confident that this paper will stimulate new research directions in this field," noted a peer reviewer in Angewandte Chemie. "It's extremely motivating that the authors of the famous Ruppert-Prakash reagent are still leading the field so many years after that initial discovery."

Explore further: Researchers turn harmful greenhouse gas into a tool for making pharmaceuticals

Related Stories

Recommended for you

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.